FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma

References

• WenPYKesariSMalignant gliomas in adultsN Engl J Med2008359549250718669428
   PubMed Web of Science ®Google Scholar
• ShinawiTHillVKKrexDDNA methylation profiles of long- and short-term glioblastoma survivorsEpigenetics20138214915623291739
   PubMed Web of Science ®Google Scholar
• SonodaYKumabeTWatanabeMLong-term survivors of glioblastoma: clinical features and molecular analysisActa Neurochir (Wien)2009151111349135819730774
   PubMed Web of Science ®Google Scholar
• ScottJNRewcastleNBBrasherPMWhich glioblastoma multiforme patient will become a long-term survivor? A population-based studyAnn Neurol199946218318810443883
   PubMed Web of Science ®Google Scholar
• DeimlingGTBowmanKFWagnerLJCancer survivorship and identity among long-term survivorsCancer Invest200725875876517952742
   PubMed Web of Science ®Google Scholar
• KrexDKlinkBHartmannCLong-term survival with glioblastoma multiformeBrain2007130pt 102596260617785346
   PubMed Web of Science ®Google Scholar
• StuppRHegiMEMasonWPEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet Oncol200910545946619269895
   PubMed Web of Science ®Google Scholar
• PradosMDLevinVBiology and treatment of malignant gliomaSemin Oncol2000273 suppl 6110
   PubMed Web of Science ®Google Scholar
• LacroixMAbi-SaidDFourneyDRA multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJ Neurosurg2001952190198
   PubMed Web of Science ®Google Scholar
• DasPPuriTJhaPA clinicopathological and molecular analysis of glioblastoma multiforme with long-term survivalJ Clin Neurosci2011181667020888234
   PubMed Web of Science ®Google Scholar
• HartmannCHentschelBSimonMLong-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutationsClin Cancer Res201319185146515723918605
   PubMed Web of Science ®Google Scholar
• JiangHRenXWangJZhangZJiaWLinSShort-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institutionJ Neurooncol2014116239540424264532
   PubMedGoogle Scholar
• KimYWKoulDKimSHIdentification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysisNeuro Oncol201315782983923502430
   PubMedGoogle Scholar
• BaurMPreusserMPiribauerMFrequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experienceRadiol Oncol201044211312022933901
   PubMed Web of Science ®Google Scholar
• ReifenbergerGWeberRGRiehmerVMolecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingInt J Cancer201413581822183124615357
   PubMedGoogle Scholar
• FranceschiSMazzantiCMLessiFInvestigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastomaOncol Lett20151063599360626788176
   PubMedGoogle Scholar
• BiWLBeroukhimRBeating the odds: extreme long-term survival with glioblastomaNeuro Oncol20141691159116025096192
   PubMed Web of Science ®Google Scholar
• LeeYLiuJPatelSGenomic landscape of meningiomasBrain Pathol201020475176220015288
   PubMedGoogle Scholar
• GravendeelLAKouwenhovenMCGevaertOIntrinsic gene expression profiles of gliomas are a better predictor of survival than histologyCancer Res200969239065907219920198
   PubMed Web of Science ®Google Scholar
• LeeYScheckACCloughesyTFGene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger ageBMC Med Genomics200815218940004
   PubMed Web of Science ®Google Scholar
• GiltayRTimplRKostkaGSequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4Matrix Biol199918546948010601734
   PubMed Web of Science ®Google Scholar
• GallaherDDKhilJThe effect of synbiotics on colon carcinogenesis in ratsJ Nutr19991297 suppl1483S1487S10395626
   PubMedGoogle Scholar
• de VegaSIwamotoTYamadaYFibulins: multiple roles in matrix structures and tissue functionsCell Mol Life Sci20096611–121890190219189051
   PubMed Web of Science ®Google Scholar
• HanSMengLWangYWuAPlasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patientsPLoS One201494e9379124690948
   PubMedGoogle Scholar
• LinYJiangTZhouKPlasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomasNeuro Oncol200911546847619164435
   PubMedGoogle Scholar
• ShaoRHamelKPetersenLYKL-40, a secreted glycoprotein, promotes tumor angiogenesisOncogene200928504456446819767768
   PubMed Web of Science ®Google Scholar
• FrancesconeRAScullySFaibishMRole of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastomaJ Biol Chem201128617153321534321385870
   PubMed Web of Science ®Google Scholar
• AkiyamaYAshizawaTKomiyamaMYKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell lineOncol Rep201432115916624842123
   PubMedGoogle Scholar
• LouisDNOhgakiHWiestlerODCaveneeWKWHO Classfication of Tumors of the Central Nervous systemLyonIARC2007
   Google Scholar
• PfafflMWA new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Res2001299e4511328886
   PubMed Web of Science ®Google Scholar
• EstellerMGarcia-FoncillasJAndionEInactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsN Engl J Med2000343191350135411070098
   PubMed Web of Science ®Google Scholar
• KanemotoMShirahataMNakaumaAPrognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter regionBMC Cancer20141464125175833
   PubMedGoogle Scholar
• Huang daWShermanBTTanQThe DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene listsGenome Biol200789R18317784955
   PubMed Web of Science ®Google Scholar
• KanehisaMThe KEGG databaseNovartis Found Symp200224791101 discussion 101–103, 119–128, 244–25212539951
   PubMed Web of Science ®Google Scholar
• VerhaakRGHoadleyKAPurdomEIntegrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell20101719811020129251
   PubMed Web of Science ®Google Scholar
• GerberNKGoenkaATurcanSTranscriptional diversity of long-term glioblastoma survivorsNeuro Oncol20141691186119524662514
   PubMed Web of Science ®Google Scholar
• ArgravesWSGreeneLMCooleyMAGallagherWMFibulins: physiological and disease perspectivesEMBO Rep20034121127113114647206
   PubMed Web of Science ®Google Scholar
• Te RietLvan DeelEDvan ThielBSAT1-receptor blockade, but not renin inhibition, reduces aneurysm growth and cardiac failure in fibulin-4 miceJ Hypertens201634465466526828783
   PubMedGoogle Scholar
• LeVPYamashiroYYanagisawaHWagenseilJEMeasuring, reversing, and modeling the mechanical changes due to the absence of Fibulin-4 in mouse arteriesBiomech Model Mechanobiol20141351081109524526456
   PubMedGoogle Scholar
• PapkeCLTsunezumiJRinguetteLJLoss of fibulin-4 disrupts collagen synthesis and maturation: implications for pathology resulting from EFEMP2 mutationsHum Mol Genet201524205867587926220971
   PubMedGoogle Scholar
• IgouchevaOAlexeevVHalabiCMFibulin-4 E57K knock-in mice recapitulate cutaneous, vascular and skeletal defects of recessive cutis laxa 1B with both elastic fiber and collagen fibril abnormalitiesJ Biol Chem201529035214432145926178373
   PubMed Web of Science ®Google Scholar
• XiangYSekineTNakamuraHFibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritisJ Immunol200617653196320416493080
   PubMedGoogle Scholar
• YueWDacicSSunQFrequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylationClin Cancer Res20071315 pt 14336434417671114
   PubMedGoogle Scholar
• FurutaJNobeyamaYUmebayashiYOtsukaFKikuchiKUshijimaTSilencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomasCancer Res200666126080608616778180
   PubMedGoogle Scholar
• ChangHRhaSYJeungHCIdentification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cellsJ Cancer Res Clin Oncol2010136121901191320217129
   PubMedGoogle Scholar
• YuenHFMcCruddenCMHuangYHTAZ expression as a prognostic indicator in colorectal cancerPLoS One201381e5421123372686
   PubMed Web of Science ®Google Scholar
• YaoLLaoWZhangYIdentification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissuesJ Proteome Res20121163281329422506683
   PubMed Web of Science ®Google Scholar
• KehrmannATruongHRepenningAComplementation of non-tumorigenicity of HPV18-positive cervical carcinoma cells involves differential mRNA expression of cellular genes including potential tumor suppressor genes on chromosome 11q13Cancer Genet20132067–827929224042169
   PubMedGoogle Scholar
• ChenJZhangJLiuXFangRZhaoYMaDOverexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinomaOncol Rep20143162601261024737201
   PubMedGoogle Scholar
• ChenJLiuZFangSFibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomasBMC Cancer2015159125885889
   PubMed Web of Science ®Google Scholar
• WlazlinskiAEngersRHoffmannMJDownregulation of several fibulin genes in prostate cancerProstate200767161770178017929269
   PubMed Web of Science ®Google Scholar
• WangLChenQChenZEFEMP2 is upregulated in gliomas and promotes glioma cell proliferation and invasionInt J Clin Exp Pathol201589103851039326617746
   PubMed Web of Science ®Google Scholar
• MarucciGMorandiLMagriniEGene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20Virchows Arch2008453659960918953566
   PubMedGoogle Scholar
• HigginsRJDickinsonPJLeCouteurRASpontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotypingJ Neurooncol2010981495519967449
   PubMedGoogle Scholar
• ZhangLHuangWChenJZhouXLuZZhouHExpression of IGFBP2 in gastric carcinoma and relationship with clinicopathologic parameters and cell proliferationDig Dis Sci200752124825317171534
   PubMedGoogle Scholar
• McDonaldKLO’ullivanMGParkinsonJFIQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patientsJ Neuropathol Exp Neurol200766540541717483698
   PubMedGoogle Scholar
• SantoshVArivazhaganASreekanthreddyPGrade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastomaCancer Epidemiol Biomarkers Prev20101961399140820501753
   PubMed Web of Science ®Google Scholar
• ZhengSHousemanEAMorrisonZDNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expressionNeuro Oncol201113328028921339190
   PubMed Web of Science ®Google Scholar
• KulkarniAThotaBSrividyaMRExpression pattern and prognostic significance of IGFBP isoforms in anaplastic astrocytomaPathol Oncol Res201218496196722547392
   PubMedGoogle Scholar
• LiYJiangTZhangJElevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studiesAnn Oncol20122392415242222357443
   PubMedGoogle Scholar
• Gallego Perez-LarrayaJParisSIdbaihADiagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastomaCancer2014120243972398025139333
   PubMed Web of Science ®Google Scholar
• LevittRJGeorgescuMMPollakMPTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2Biochem Biophys Res Commun200533641056106116154532
   PubMedGoogle Scholar
• Mehrian-ShaiRChenCDShiTInsulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancerProc Natl Acad Sci U S A2007104135563556817372210
   PubMedGoogle Scholar
• JiangRMirceanCShmulevichIPathway alterations during glioma progression revealed by reverse phase protein lysate arraysProteomics20066102964297116619307
   PubMedGoogle Scholar
• WangGKHuLFullerGNZhangWAn interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobilityJ Biol Chem200628120140851409116569642
   PubMed Web of Science ®Google Scholar
• HolmesKMAnnalaMChuaCYInsulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-kappaB networkProc Natl Acad Sci U S A201210993475348022345562
   PubMedGoogle Scholar
• HanSLiZMasterLMMasterZWWuAExogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin beta1-ERK pathwayBr J Cancer201411171400140925093489
   PubMedGoogle Scholar
• WangHShenWHuangHInsulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genesCancer Res200363154315432112907597
   PubMedGoogle Scholar
• GodardSGetzGDelorenziMClassification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypesCancer Res200363206613662514583454
   PubMed Web of Science ®Google Scholar
• ZhouYHHessKRLiuLLinskeyMEYungWKModeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variablesNeuro Oncol20057448549416212813
   PubMed Web of Science ®Google Scholar
• FukushimaTTezukaTShimomuraTNakanoSKataokaHSilencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24J Biol Chem200728225186341864417475624
   PubMedGoogle Scholar
• Martino-EcharriEFernandez-RodriguezRBech-SerraJJRelevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1Oncotarget20145124295430424962328
   PubMedGoogle Scholar
• MooreLMHolmesKMSmithSMIGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomasProc Natl Acad Sci U S A200910639166751667919805356
   PubMedGoogle Scholar
• LiXLiuYGranbergKJTwo mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastomaOncogene201534131619162824747968
   PubMedGoogle Scholar